Your browser doesn't support javascript.
loading
Cancer-associated S100P protein binds and inactivates p53, permits therapy-induced senescence and supports chemoresistance.
Gibadulinova, Adriana; Pastorek, Michal; Filipcik, Pavel; Radvak, Peter; Csaderova, Lucia; Vojtesek, Borivoj; Pastorekova, Silvia.
Affiliation
  • Gibadulinova A; Institute of Virology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovak Republic.
  • Pastorek M; Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
  • Filipcik P; Institute of Virology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovak Republic.
  • Radvak P; Institute of Virology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovak Republic.
  • Csaderova L; Institute of Virology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovak Republic.
  • Vojtesek B; Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
  • Pastorekova S; Institute of Virology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovak Republic.
Oncotarget ; 7(16): 22508-22, 2016 Apr 19.
Article in En | MEDLINE | ID: mdl-26967060
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Calcium-Binding Proteins / Tumor Suppressor Protein p53 / Cellular Senescence / Drug Resistance, Neoplasm / Neoplasm Proteins Type of study: Risk_factors_studies Limits: Humans Language: En Year: 2016 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Calcium-Binding Proteins / Tumor Suppressor Protein p53 / Cellular Senescence / Drug Resistance, Neoplasm / Neoplasm Proteins Type of study: Risk_factors_studies Limits: Humans Language: En Year: 2016 Type: Article